Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

NOA

Financiado

Cerrado

NOA a disruptive portable device to monitor asthma

In Europe, about 30 million children and adults under 45 years old have asthma. There is no cure for asthma, it is a chronic disease. Asthma can have a very negative impact on the quality of life of those people who suffer from it... ver más

30/11/2017

EVERSENS

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

EVERSENS 1.- el diseño y desarrollo de equipos y plataformas de instrumentación y medida. 2.- la fabricación, compra, alquiler y venta, incluyendo el...

TRL 6-7 | 100K€

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2017-11-30

SMEInst-01-2016-2017: Open Disruptive Innovation Scheme

I+D

Cerrada hace 8 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

EVERSENS

50.00K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

ASTHMAPOC Disposable nitric oxide POC point of care test for home ca... 71K€ Cerrado

FrEBT Improving diagnostics of respiratory diseases and boosting t... 71K€ Cerrado

BREATHE EasyFlow New asthma monitor to enable the effective control... 71K€ Cerrado

A3BL Airofit Better Breathing Better Life 71K€ Cerrado

myAirCoach Analysis modelling and sensing of both physiological and en... 5M€ Cerrado

DiaMon Continuous Diaphragm Monitoring of mechanically ventilated p... 3M€ Cerrado

Duración del proyecto: 6 meses Fecha Inicio: 2017-05-17
Fecha Fin: 2017-11-30

Líder del proyecto

EVERSENS 1.- el diseño y desarrollo de equipos y plataformas de instrumentación y medida. 2.- la fabricación, compra, alquiler y venta, incluyendo el...

TRL 6-7 | 100K€

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto In Europe, about 30 million children and adults under 45 years old have asthma. There is no cure for asthma, it is a chronic disease. Asthma can have a very negative impact on the quality of life of those people who suffer from it. However, it can be diagnosed and effectively controlled at an early stage. The total cost of the disease for the European population aged between 15 and 64 was EUR 19.3 billion per year. We have developed the NOA device, that monitors asthma in a simple, painless, non-invasive and precise way, with accurate and immediate results. The NOA is useful for both preventive and post-treatment monitoring. The basis of the NOA device is its ability to measure the Fraction of Exhaled Nitric Oxide (FeNO) of human breath, which is a marker that indicates the existence and extent of inflammation to the upper airways caused by asthma. The NOA is the only portable device able of monitoring asthma with high accuracy, and is easy to use and very fast (5 seconds) because of an innovative patent-protected technological development that combines electronics and pneumatics, sensors and mathematical algorithms. Our solution is based on studies carried out with high scientific rigor, which allows us to guarantee the validity of the NOA. The NOA device has been successfully tested by more than 100 people and 35 doctors. Our client’s segments are hospitals with departments of allergology and/or pneumology and pharmacies. The NOA has important advantages in regard to convenience, speed of the test, price and business model, making it feasible for pharmacies to offer a service that has, up to now, not been on offer. The general objective of the Innovation Project is to bring the NOA device to the European market. Phase 1 of SME Instrument represents an opportunity to get a thorough business plan to minimize risks.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores